Search
for
Sort by
Research 811–840 of 934
- Janus kinase inhibitors for alopecia areata
- Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata
- Treatment options and emotional well-being in patients with rosacea: An unsupervised machine learning analysis of over 200,000 posts
- Baricitinib for the Treatment of Alopecia Areata
- Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey
- Gender-Difference in Hair Length as Revealed by Crispr-Based Production of Long-Haired Mice with Dysfunctional FGF5 Mutations
- Coffea arabica: An Emerging Active Ingredient in Dermato-Cosmetic Applications
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Autosomal recessive monilethrix: Novel variants of the <i>DSG4</i> gene in three Chinese families
- Scanning electron microscopy of murine skin ultrathin sections and cultured keratinocytes
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Clinical Presentations and Comorbidities of Pediatric Alopecia Areata
- Correlation of clinical and trichoscopy features with the degree of histologic inflammation in lichen planopilaris and frontal fibrosing alopecia in a cross-sectional study
- A Novel Atypical Presentation of Frontal Fibrosing Alopecia Involving the Frontoparietal Scalp
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Alopecia areata: medical treatments
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- The impact, prevalence, and association of different forms of hair loss among individuals with anxiety disorder: Systematic review and meta-analysis
- JAK inhibition decreases the autoimmune burden in Down syndrome
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Alopecia Areata of the Nails: Diagnosis and Management
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Janus kinase inhibitors for alopecia areata: A narrative review
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study